CPHI & PMEC India 2024: A Grand Showcase of India’s Pharmaceutical Industry And Its Global Impact
CPHI & PMEC India 2024 highlights global pharma leadership with 50,000+ visitors and 2,000 exhibitors.
Breaking News
Dec 05, 2024
Simantini Singh Deo
(1).png)
Greater Noida, Delhi-NCR – 5th December 2024 – The 17th edition of CPHI & PMEC India, organized by Informa Markets in India, concluded successfully at the India Expo Centre, Greater Noida, Delhi-NCR, reinforcing the strong potential of India’s pharmaceutical sector. With the Indian pharma market projected to grow to $130 billion by 2030 and $450 billion by 2047, this year’s event highlighted the industry’s vital contribution to global healthcare.
Attracting over 50,000 visitors and 2,000 exhibitors from more than 150 countries, including the USA, UAE, South Korea, Japan, and the United Kingdom, CPHI & PMEC India provided a platform for industry leaders, innovators, and stakeholders to connect, collaborate, and exchange knowledge. The expo covered a wide range of sectors, from pharmaceutical machinery and packaging to laboratory technologies, ingredients, and more.
Event Inauguration Sets The Stage For Success
The grand opening ceremony set a spectacular tone for the event. Distinguished dignitaries including K. Raja Bhanu, Director General, Pharmexcil; Harish K. Jain, President, FOPE; Namit Joshi, Vice Chairman, Pharmexcil; AVPS Chakravarthy, Global Ambassador, WPO; Rhonda Duffy, Executive VP & COO, Biocon Biologics; Rakesh Kumar, Chairman, India Expo Mart (IEML) & Director General, Export Promotion Council for Handicrafts (EPCH); RK Jain, Chairman, CPI; Ranjana Ganguly, Board Member, PCSI; Yogesh Mudras, Managing Director, Informa Markets in India; Wouter Moulman, Chief Commercial Officer, Informa Markets IMEA; Adam Anderson, Executive VP – Pharma, Informa Markets B.V.; and Rahul Deshpande, Sr. Group Director, Informa Markets in India graced the occasion, marking the start of a dynamic week for the pharmaceutical industry.
A Comprehensive Exhibit Of Innovation And Expertise
Leading pharmaceutical companies such as Dr. Reddy’s Laboratories, Biocon, Glenmark Lifesciences, Morepen Laboratories, Hetero Labs, Lupin, and Merck Life Science showcased their cutting-edge innovations at the event. The PMEC pavilion highlighted the latest advancements in pharmaceutical manufacturing technologies, featuring prominent exhibitors such as ACG, Accupack Engineering, Avish Machines, Fette India, and Truking Technology. The event also provided a unique opportunity to explore advancements in packaging, tablet fillers, process automation, and filtration systems, reinforcing India’s position as a hub of pharmaceutical innovation.
This year, the expo received great backing from key industry groups like CIPI, FOPE (Federation of Pharma Entrepreneurs), IPEC India, and Pharmexcil, solidifying its position as a major and eagerly awaited event in the pharmaceutical sector.
AVPS Chakravarthy, Global Ambassador, WPO, stated, “The Indian pharmaceutical industry is demonstrating its innovative potential through advancements like Carticel therapy for cancer treatment and Nafithromycin, a groundbreaking macrolide antibiotic tackling drug-resistant pathogens. These innovations highlight India’s dual strengths in affordability and efficacy, reaffirming its role as the ‘pharmacy of the world.’ Events like CPHI & PMEC India provide vital platforms for collaboration, showcasing progress in AI-driven drug inspection, sustainable packaging, and startup-driven innovations, propelling the industry towards a future of higher value creation and global leadership in both volume and value.”
Harish K Jain, President, FOPE (Federation of Pharma Entrepreneurs), said “India’s pharmaceutical industry, valued at $60 billion today, plays a vital role in global exports, with $30 billion of that in exports. By 2030, we expect our exports to grow significantly, with 70 per cent directed to Europe and the US. Our industry’s impact is enormous—Indian pharmaceuticals contribute $8 billion annually to the US healthcare system, saving patients over $1.5 trillion. With growing capabilities in AI, machine learning, and biologics, India is poised to become the world’s leading pharmaceutical hub, targeting a $1 trillion industry by 2047.”
Yogesh Mudras, MD of Informa Markets in India, emphasized the importance of this year’s CPHI & PMEC India Expo, stating, “The Indian pharmaceutical industry stands as a pillar of manufacturing excellence, scale, and research-led competitiveness. Having evolved into a vibrant sector, it now ranks 3rd globally in pharmaceutical production by volume and 14th by value, contributing approximately 1.72 per cent to the nation’s GDP. India is among the top 12 global biotechnology destinations and the third largest in the Asia-Pacific region.
He further added, “This leadership stems from key advantages such as a low manufacturing cost, which is 30 percent - 35 percent lower than in the US and Europe, cost-efficient R&D at 87 per cent less than developed markets, and an abundant pool of skilled labour. These strengths position India as a formidable player in shaping the future of global healthcare. The CPHI & PMEC India expo acts as a catalyst in propelling the pharmaceutical industry’s progress, fostering transformative innovations, strategic collaborations, and impactful global synergies. We are also proud to have a Start-Up Pavilion under the aegis of the expo, which showcases emerging pharma disruptors with cutting-edge solutions that challenge traditional approaches. This offers attendees a glimpse into the future of the industry.”
Day 1 Highlights: Industry Insights and Awards
Day 1 of the event featured the Pharma Connect Congress, which addressed key topics shaping the pharmaceutical landscape. Noteworthy sessions included discussions on continuous innovation for next-generation therapeutics, India’s growing prominence as the “Pharmacy of the World,” and the challenges of digital transformation within the sector. Renowned speakers like Dr. Mahesh Bhalgat, Group CEO & MD, Veeda Clinical Research, and Dr. Rhonda Duffy, Executive VP & COO, Biocon Biologics, provided invaluable insights.
The day concluded with the prestigious India Pharma Awards 2024, where the industry’s best in R&D, sustainability, and digital innovation were recognized, including the Lifetime Achievement Award for individuals who have made significant contributions to the pharmaceutical sector.
Day 2 Focus: Sustainability, Leadership, and Women in Pharma
Day 2 of the event was dedicated to exploring sustainability within the pharmaceutical and biopharma sectors. Sessions covered key sustainability challenges, navigating environmental regulations, and integrating green chemistry into drug discovery. Keynote speakers included AVPS Chakravarthi, Global Ambassador, World Packaging Organisation, and Dr. Pramod Wangikar, Chair Professor for Green Chemistry at IIT Bombay.
A highlight of Day 2 was the Women in Pharma Roundtable, which explored the evolving role of women in the pharmaceutical and healthcare industries. The session focused on overcoming challenges such as pay disparity and leadership gaps, while also providing insights on emerging opportunities for women to excel in the sector.
Pharma Now: Amplifying The Event’s Visibility And Reach
As a proud media partner, Pharma Now played a crucial role in amplifying the event’s visibility and global reach. Through its extensive network, Pharma Now ensured that the event's highlights, expert discussions, and key innovations were shared with a wide audience, contributing to the overall success of CPHI & PMEC India 2024.
About CPHI & PMEC India
CPHI & PMEC India 2024 remains the premier event for the pharmaceutical industry in India, bringing together key players from across the globe to explore the latest innovations and advancements in the pharma and biopharma sectors. The event features a comprehensive exhibition covering Active Pharmaceutical Ingredients (APIs), excipients, drug formulations, packaging, pharmaceutical machinery, and more. The event also provides a platform for networking, collaboration, and exploring strategic business opportunities.
For more information about CPHI & PMEC India 2024, please visit their website!
About Pharma Now
Pharma Now is a leading media platform that provides the latest news, insights, and updates from the pharmaceutical industry. As a proud media partner for CPHI & PMEC India 2024, Pharma Now played an integral role in amplifying the event’s impact and visibility, ensuring that the discussions and innovations showcased during the event reached a broader global audience.
For media inquiries, please contact